发现和评估SA-18作为一种抗毒体剂的发现和评估
Huiyu Du1, Wanxin Luo2, Hongxi Zhang1
1State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
概括
一种新型的方胺衍生物SA-18对Toxoplasma gondii表现出强烈的活性,抑制了tachyzoite和bradyzoite阶段. 这种化合物为治疗毒素菌提供了一个有前途的新途径,特别是在耐药病例中.
科学领域:
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 毒素菌是一种广泛传播的寄生虫,会引起严重的健康问题,特别是在免疫力低下的人群中.
- 目前对毒素菌的治疗方法对慢性布拉迪佐इट阶段无效,并面临日益增长的耐药性.
研究的目的:
- 为了选imidocarb衍生物的抗毒素菌活性.
- 为了确定新的治疗候选人对毒素菌.
- 为了研究有前途的化合物的作用机制.
主要方法:
- 合成和选20种伊米多碳酸衍生物.
- 试验室测试以确定EC50对太基菌和抑制布拉迪菌分化.
- 转录组分析以确定受影响的寄生虫通路.
- 在小鼠模型中进行体内研究,以评估疗效和存活率.
主要成果:
- 斯夸拉胺衍生物18 (SA-18) 证明了纳米分子EC50对抗太基和强大的抑制布拉迪分化.
- 在SA-18中,选择性指数大于100.
- 转录组分析显示了寄生虫代谢途径的调节失调以及布拉迪佐伊特标记物BAG1.1的降低调节.
- 在体内研究表明,小鼠的寄生虫负载显著减少,尽管生存率低于最佳水平.
结论:
- SA-18是一种有前途的新型化合物用于治疗毒素菌,有效对抗多个寄生虫阶段.
- 该化合物的机制涉及破坏寄生虫的代谢途径.
- 进一步优化SA-18是必要的,以成功临床翻译在治疗毒素菌.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
573
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
573
Drug Discovery: Overview
11.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.8K
Subviral Agents
580
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
580
Air-entraining Agents
276
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
276
Masking and Demasking Agents
3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K


